Zak Doric invests in biotechnology companies as an investing partner on Andreessen Horowitz’s Bio + Health team. He previously developed biotech venture hypotheses at Flagship Pioneering and researched molecular mechanisms behind familial Parkinson’s disease while earning his UCSF neuroscience PhD.
Zak Doric invests in biotechnology companies as an investing partner on Andreessen Horowitz’s Bio + Health team. He previously developed biotech venture hypotheses at Flagship Pioneering and researched molecular mechanisms behind familial Parkinson’s disease while earning his UCSF neuroscience PhD.
Career
Zak Doric holds a PhD, Neuroscience from University of California, San Francisco and a BSc, Neuroscience from McGill University.
Investing Partner, Bio + Health (promoted from Investing Analyst) at Andreessen Horowitz (a16z) from 2022-04 to PresentFocuses on biotechnology investments.GIGraduate Researcher at Gladstone Institutes / UCSF from 2016-09 to 2022-03Studied molecular mechanisms responsible for familial forms of Parkinson's disease as a UCSF Hillblom Graduate Fellow.
Fellow at Flagship Pioneering from 2021-06 to 2021-08Created venture hypotheses for new biotechnology company-creation efforts.
ADvantage Intern at Bain & Company from 2021-05 to 2021-05